Alexandros Spyridonidis
Patra, ESYE23, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications
Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.
Journal: Bone marrow transplantation
Published: March 21, 2026
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT.
Journal: Bone marrow transplantation
Published: March 15, 2026
Real-World Outcomes in NPM1-Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse.
Journal: American journal of hematology
Published: January 30, 2026
Chronic graft-versus-host disease: Current situation and unmet needs - A European position statement.
Journal: Bone marrow transplantation
Published: December 24, 2025
Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries.
Journal: Blood cancer journal
Published: December 19, 2025
Current role of ATG in GVHD prevention: optimizing post-transplantation outcomes through combination with PTCY.
Journal: Current opinion in immunology
Published: December 08, 2025
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.
Journal: Bone marrow transplantation
Published: November 23, 2025
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.
Journal: Bone marrow transplantation
Published: November 19, 2025
Microbiotherapy and fecal microbiota transplantation in hematology-oncology: a European clinical perspective to navigate the evolving regulatory framework and the emergence of a new therapeutic class.
Journal: Bone marrow transplantation
Published: October 17, 2025
Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party.
Journal: Bone marrow transplantation
Published: October 03, 2025
Harnessing the immunomodulatory properties of HLA-G for advanced immunotherapies.
Journal: Frontiers in immunology
Published: September 30, 2025
Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: September 19, 2025
Last Updated: 09/26/2026